Terms: = Lung cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
752 results:
1. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
2. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract] [Full Text] [Related]
3. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
[TBL] [Abstract] [Full Text] [Related]
4. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
Huang X; Wu S; Chen S; Qiu M; Zhao Y; Wei J; He J; Zhao W; Tan L; Su C; Zhou S
Int Immunopharmacol; 2024 May; 132():111901. PubMed ID: 38554448
[TBL] [Abstract] [Full Text] [Related]
6. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
Wang N; Tan X; Cao S; Liu M
Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
[TBL] [Abstract] [Full Text] [Related]
7. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
8. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/akt pathway via interaction with TWIST1.
Xu T; Yin F; Shi K
Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
[TBL] [Abstract] [Full Text] [Related]
9. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/akt/VEGFA signaling pathway.
Qian S; Wang F; Liao W; Liu J
Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
[TBL] [Abstract] [Full Text] [Related]
10. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
11. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
[TBL] [Abstract] [Full Text] [Related]
12. Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity.
Lv Q; Zhang J; Cai J; Chen L; Liang J; Zhang T; Lin J; Chen R; Zhang Z; Guo P; Hong Y; Pan L; Ji H
Chem Biol Interact; 2024 Apr; 393():110947. PubMed ID: 38479716
[TBL] [Abstract] [Full Text] [Related]
13. Activation of the PI3K/akt signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
14. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
Lin Y; Dong C; Zhang J; Zhu Y
Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
[TBL] [Abstract] [Full Text] [Related]
15. G protein-coupled estrogen receptor activates PI3K/akt/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis.
Chen J; Zhao R; Wang Y; Xiao H; Lin W; Diao M; He S; Mei P; Liao Y
Mol Med; 2024 Feb; 30(1):28. PubMed ID: 38383297
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/akt signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract] [Full Text] [Related]
17. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
18. Plin2 inhibits autophagy via activating akt/mTOR pathway in non-small cell lung cancer.
Wang Y; Hu Y; Xu R; Jin X; Jiao W
Exp Cell Res; 2024 Feb; 435(2):113955. PubMed ID: 38301990
[TBL] [Abstract] [Full Text] [Related]
19. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
[TBL] [Abstract] [Full Text] [Related]
20. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
[Next]
